| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |